Jazz los­es ap­peal, will have patent delist­ed from the Or­ange Book

The US Court of Ap­peals for the Fed­er­al Cir­cuit is up­hold­ing an in­junc­tion that states that a patent re­lat­ed to Jazz Phar­ma­ceu­ti­cals’ nar­colep­sy drug should …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.